Hinge Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Daniel A. Perez
- Full Time Employees
- 1,437
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 455 Market Street San Francisco CA United States of America 94105
- IPO Date
- May 22, 2025
- CIK
- 0001673743
- Website
- hingehealth.com
- Similar Companies
- Business
- Hinge Health, Inc. Hinge Health, Inc. (NYSE: HNGE) provides a digital platform delivering musculoskeletal (MSK) care through virtual physical therapy, AI-powered technologies, wearable devices, and clinician support services; core offerings include the Enso wearable for motion tracking and feedback, TrueMotion computer vision for exercise form correction, personalized exercise therapy programs, behavioral health coaching, patient education content, and specialized pelvic health programs for women; the platform addresses acute injuries, chronic pain, post-surgical rehabilitation, and joint/muscle conditions to reduce surgeries, opioid use, and healthcare costs for employers, health plans, and over 1 million members across more than 2,250 clients including nearly half of the Fortune 100. Founded in 2014 by Daniel Perez and Gabriel Mecklenburg and headquartered at 455 Market Street in San Francisco, California, the company operates primarily in the United States with expansion into Canada in 2024 and planned entry into Europe in 2025; it serves self-insured employers, national/regional health plans, and pharmacy benefit managers through its AI-driven HingeConnect database that identifies high-risk patients and optimizes care delivery. In May 2025, Hinge Health completed its initial public offering on the NYSE, raising approximately $437 million by selling 9.14 million shares at $32 each, opening at $39.25 and closing at $37.56 to mark a successful public market debut following prior private rounds including $400 million Series E in 2021; the company reported 53% year-over-year revenue growth to $154 million in Q3 2025 while advancing AI-enabled features that reduce physical therapy care hours by 95% and enhance member adherence and outcomes.
Company News
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
15 Stocks to Watch With Short Squeeze Potential
IPO Stock Of The Week: Hinge Health Finds Support At Key Level, Eyes New Buy Points
One Platform, Every Ailment: Hinge Health's Gamble
HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum
Is the Options Market Predicting a Spike in Hinge Health Stock?
Jim Cramer Recommends Buying This Health Care Stock: ‘What A Quarter They Had'
Assenagon Asset Management S.A. Invests $6.87 Million in Hinge Health Inc. $HNGE
Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks
Hinge Health (NYSE:HNGE) Shares Up 9.5% After Earnings Beat
HNGE Q2 Earnings Meet Estimates, Sales Top, '26 View Raised, Stock Up
Hinge Health Q2 Earnings Call Highlights
Hinge Health Q2 Earnings Call Highlights
Hinge Health, Inc. (HNGE) Q2 2026 Earnings Call Transcript
Hinge Health Inc. (HNGE) Q2 Earnings Meet Estimates
Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care